214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33819-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer

American Journal of Hematology
Hematology
2019English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncology
Cancer ResearchOncology
2018English

Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons

Neurosurgical Focus
MedicineSurgeryNeurology
2018English

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
2013English

Generation of Potent T-Cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Cancer immunology research
Cancer ResearchImmunology
2015English

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications

Frontiers in Immunology
AllergyImmunology
2017English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy